195 related articles for article (PubMed ID: 8344792)
41. [Antibody titers in the serum of patients vaccinated with the multicomponent vaccine consisting of toxoids of protease, elastase and a common protective antigen (OEP)].
Yamamoto M; Kubota Y; Matsuura M; Homma JY
Kansenshogaku Zasshi; 1986 Nov; 60(11):1178-83. PubMed ID: 3102639
[No Abstract] [Full Text] [Related]
42. Pseudomonas aeruginosa exotoxin A and keratitis in mice.
Pillar CM; Hobden JA
Invest Ophthalmol Vis Sci; 2002 May; 43(5):1437-44. PubMed ID: 11980858
[TBL] [Abstract][Full Text] [Related]
43. Effect of vitamin A deficiency on the early response to experimental Pseudomonas keratitis.
Twining SS; Zhou X; Schulte DP; Wilson PM; Fish B; Moulder J
Invest Ophthalmol Vis Sci; 1996 Mar; 37(4):511-22. PubMed ID: 8595951
[TBL] [Abstract][Full Text] [Related]
44. Proteolytic cleavage of exotoxin A from Pseudomonas aeruginosa: formation of an ADP-ribosyltransferase active fragment by the action of Pseudomonas elastase.
Sanai Y; Morihara K; Tsuzuki H; Homma JY; Kato I
FEBS Lett; 1980 Oct; 120(1):131-4. PubMed ID: 6254804
[No Abstract] [Full Text] [Related]
45. Inhibition of Pseudomonas aeruginosa elastase and Pseudomonas keratitis using a thiol-based peptide.
Burns FR; Paterson CA; Gray RD; Wells JT
Antimicrob Agents Chemother; 1990 Nov; 34(11):2065-9. PubMed ID: 2127341
[TBL] [Abstract][Full Text] [Related]
46. Comparative in vitro exoenzyme-suppressing activities of azithromycin and other macrolide antibiotics against Pseudomonas aeruginosa.
Mizukane R; Hirakata Y; Kaku M; Ishii Y; Furuya N; Ishida K; Koga H; Kohno S; Yamaguchi K
Antimicrob Agents Chemother; 1994 Mar; 38(3):528-33. PubMed ID: 8203850
[TBL] [Abstract][Full Text] [Related]
47. Detection by enzyme-linked immunosorbent assays of antibody specific for Pseudomonas proteases and exotoxin A in sera from cystic fibrosis patients.
Jagger KS; Robinson DL; Franz MN; Warren RL
J Clin Microbiol; 1982 Jun; 15(6):1054-8. PubMed ID: 6809785
[TBL] [Abstract][Full Text] [Related]
48. Isolation and characterization of a Pseudomonas aeruginosa gene, ptxR, which positively regulates exotoxin A production.
Hamood AN; Colmer JA; Ochsner UA; Vasil ML
Mol Microbiol; 1996 Jul; 21(1):97-110. PubMed ID: 8843437
[TBL] [Abstract][Full Text] [Related]
49. Production of elastase and other exoproducts by environmental isolates of Pseudomonas aeruginosa.
Nicas TI; Iglewski BH
J Clin Microbiol; 1986 May; 23(5):967-9. PubMed ID: 3086372
[TBL] [Abstract][Full Text] [Related]
50. Production of elastase, exotoxin A, and alkaline protease in sputa during pulmonary exacerbation of cystic fibrosis in patients chronically infected by Pseudomonas aeruginosa.
Jaffar-Bandjee MC; Lazdunski A; Bally M; Carrère J; Chazalette JP; Galabert C
J Clin Microbiol; 1995 Apr; 33(4):924-9. PubMed ID: 7790462
[TBL] [Abstract][Full Text] [Related]
51. A Pseudomonas aeruginosa alginate-exotoxin A conjugate that elicits anti-alginate and exotoxin A-neutralizing antibodies.
Coin D; Vacheron MJ; Guinand M; Michel G
FEMS Microbiol Immunol; 1991 Aug; 3(4):185-92. PubMed ID: 1931130
[TBL] [Abstract][Full Text] [Related]
52. Alkaline protease-deficient mutants of Pseudomonas aeruginosa are virulent in the eye.
Pillar CM; Hazlett LD; Hobden JA
Curr Eye Res; 2000 Sep; 21(3):730-9. PubMed ID: 11120561
[TBL] [Abstract][Full Text] [Related]
53. Relation between antibody response to Pseudomonas aeruginosa exoproteins and colonization/infection in patients with cystic fibrosis.
Granström M; Ericsson A; Strandvik B; Wretlind B; Pavlovskis OR; Berka R; Vasil ML
Acta Paediatr Scand; 1984 Nov; 73(6):772-7. PubMed ID: 6441448
[TBL] [Abstract][Full Text] [Related]
54. Elastase and alkaline protease production by Pseudomonas aeruginosa strains: comparison of two procedures.
Yagci A; Tuc Y; Soyletir G
New Microbiol; 2002 Apr; 25(2):223-9. PubMed ID: 12019729
[TBL] [Abstract][Full Text] [Related]
55. Epidemic population structure of Pseudomonas aeruginosa: evidence for a clone that is pathogenic to the eye and that has a distinct combination of virulence factors.
Lomholt JA; Poulsen K; Kilian M
Infect Immun; 2001 Oct; 69(10):6284-95. PubMed ID: 11553572
[TBL] [Abstract][Full Text] [Related]
56. In vivo characterization of host and bacterial protease expression during Pseudomonas aeruginosa corneal infections in naive and immunized mice.
Kernacki KA; Fridman R; Hazlett LD; Lande MA; Berk RS
Curr Eye Res; 1997 Apr; 16(4):289-97. PubMed ID: 9134316
[TBL] [Abstract][Full Text] [Related]
57. Pseudomonas aeruginosa mutants altered in their sensitivity to the effect of iron on toxin A or elastase yields.
Sokol PA; Cox CD; Iglewski BH
J Bacteriol; 1982 Aug; 151(2):783-7. PubMed ID: 6807961
[TBL] [Abstract][Full Text] [Related]
58. Enzyme-linked immunosorbent assay for detection of antibodies to Pseudomonas aeruginosa exoproteins.
Granström M; Wretlind B; Markman B; Pavlovskis OR; Vasil ML
Eur J Clin Microbiol; 1985 Apr; 4(2):197-200. PubMed ID: 3924608
[TBL] [Abstract][Full Text] [Related]
59. Pseudomonas aeruginosa antibody detection in cystic fibrosis patients.
Trancassini M; De Vito D; Quattrucci S; Cipriani P
New Microbiol; 1999 Apr; 22(2):85-9. PubMed ID: 10322606
[TBL] [Abstract][Full Text] [Related]
60. Extrahepatic synthesis of plasminogen in the human cornea is up-regulated by interleukins-1alpha and -1beta.
Twining SS; Wilson PM; Ngamkitidechakul C
Biochem J; 1999 May; 339 ( Pt 3)(Pt 3):705-12. PubMed ID: 10215610
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
